← Leaderboards
James H Chesebro
Mount Sinai School Of Medicine Of Cuny
$47,556
Attributed
$47,556
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$47,556 · 2
By mechanism
M01$47,556 · 2
Top collaborators
No co-investigators on record.
Most similar at Mount Sinai School Of Medicine Of Cuny
Same institution · by research overlap
- Mark B Taubman$12,009,660
- Robert A. Phillips$3,876,071
- Horacio Kaufmann$10,533,467
- Juan Jose Badimon$4,658,014
- Susan Morgello$54,997,919
Others in their field
Top investigators on “Cardiovascular Disorder Chemotherapy”
- James F Toole · Wake Forest University Health Sciences$17,951,480
- Christopher M O'Connor · Duke University$16,943,599
- Leslie L Robison · University Of Minnesota Twin Cities$16,102,450
- Oscar R Benavente · University Of Texas Hlth Sci Ctr San Ant$14,553,633
- Dan M Roden · Vanderbilt University Medical Center$11,317,563
- Andrew G. Bostom · Rhode Island Hospital (Providence, Ri)$10,300,000
Research focus
Cardiovascular Disorder ChemotherapyClinical ResearchHuman SubjectHuman Therapy EvaluationCardiovascular PharmacologyChronic Disease /DisorderClinical TrialsCombination ChemotherapyCoronary DisorderDosageDrug Administration Rate /DurationDrug Screening /EvaluationHeparinHirudinsMyocardial InfarctionPharmacokineticsPlatelet Aggregation InhibitorsAngina PectorisThrombosisArteryAspirinCardiovascular Disorder Prevention
Grant awards (6)
CLOPIDOGREL DOSING IN HUMAN ARTERIAL THROMBUS FORMATION$0
M01 · FY2002 · RR
HIRUDIN IN ANGINA OR NON-O WAVE INFARCTION$0
M01 · FY2002 · RR
CLOPIDOGREL DOSING IN HUMAN ARTERIAL THROMBUS FORMATION$0
M01 · FY2001 · RR
HIRUDIN IN ANGINA OR NON-O WAVE INFARCTION$0
M01 · FY2001 · RR
CLOPIDOGREL DOSING IN HUMAN ARTERIAL THROMBUS FORMATION$47,556
M01 · FY2000 · RR
HIRUDIN IN ANGINA OR NON-O WAVE INFARCTION$0
M01 · FY2000 · RR